DTaP-IPV-HepB vaccine

DTaP-IPV-HepB vaccine
Combination of
DTaP vaccine	Vaccine
Inactivated poliovirus vaccine	Vaccine
Hepatitis B vaccine	Vaccine
Clinical data
Trade names	Pediarix
AHFS/Drugs.com	Pediarix
MedlinePlus	a607014
License data	US DailyMed: Pediarix;
Pregnancy; category	US: C (Risk not ruled out) ;
Routes of; administration	IM
ATC code	J07CA12 (WHO) ;
Legal status
Legal status	US: ℞-only ;

DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine or DTaP-IPV-Hep B.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.[2][3][4]

A branded formulation is marketed in the U.S. as Pediarix by GlaxoSmithKline.[5]

References

"Diphtheria, Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Poliovirus (Inactivated) Vaccine". Drugs.com. Retrieved 15 July 2018.
Centers for Disease Control Prevention (CDC) (March 2003). "FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants". MMWR Morb. Mortal. Wkly. Rep. 52 (10): 203–4. PMID 12653460.
Centers for Disease Control Prevention (CDC) (October 2008). "Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose". MMWR Morb. Mortal. Wkly. Rep. 57 (39): 1078–9. PMID 18830212.
Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP (January 2018). "Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices". MMWR Recomm Rep. 67 (1): 1–31. doi:10.15585/mmwr.rr6701a1. PMC 5837403. PMID 29939980.
"Pediarix". Food and Drug Administration (FDA). 21 February 2018. Retrieved 22 September 2019.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "Diphtheria, Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Poliovirus (Inactivated) Vaccine". Drugs.com. Retrieved 15 July 2018.

[2] Centers for Disease Control Prevention (CDC) (March 2003). "FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants". MMWR Morb. Mortal. Wkly. Rep. 52 (10): 203–4. PMID 12653460.

[3] Centers for Disease Control Prevention (CDC) (October 2008). "Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose". MMWR Morb. Mortal. Wkly. Rep. 57 (39): 1078–9. PMID 18830212.

[4] Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP (January 2018). "Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices". MMWR Recomm Rep. 67 (1): 1–31. doi:10.15585/mmwr.rr6701a1. PMC 5837403. PMID 29939980.

[5] "Pediarix". Food and Drug Administration (FDA). 21 February 2018. Retrieved 22 September 2019.